Dr. Reddy’s Laboratories Limited engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

dr. reddy’s laboratories limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Generic. dr. reddy’s laboratories limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE089A01023
Equity Stock (National Stock Exchange) Symbol: DRREDDY
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=DRREDDY
BSE Link IS: https://www.bseindia.com/stock-share-price/dr-reddys-laboratories-ltd/DRREDDY/500124/

Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.

Global Generics Segment (~80% of revenues) This is the main business of the company wherein it offers 400+ high-quality generic drugs, keeping costs reasonable by leveraging its integrated operations. The company benefits from its expertise in active ingredients, product development skills, a keen understanding of regulations and intellectual property rights & streamlined supply chain.

Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com For more information, log on to: www.drreddys.com

Dr. Reddy’s Laboratories stand with [We accelerate access to affordable and innovative medicines because Good Health Can’t Wait.]

Company Website: http://www.drreddys.com/
Company Website2: http://www.drreddys.com/
LinkedIn page URL: https://in.linkedin.com/company/dr–reddys-laboratories
Wiki Profile URL: https://en.wikipedia.org/wiki/Dr._Reddy’s_Laboratories

Popular Search Keywords: dr. reddy’s laboratories limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Generic industry

#dr #reddy’s #laboratories #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #generic #industry

The post Dr. Reddy’s Laboratories Limited Company Profile – KooCapital.Com | Stock Market News appeared first on KooCapital.Com.

Alkem Laboratories Limited engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals. The company was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973 and is headquartered in Mumbai, India.

alkem laboratories limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Generic. alkem laboratories limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE540L01014
Equity Stock (National Stock Exchange) Symbol: ALKEM
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=ALKEM
BSE Link IS: https://www.bseindia.com/stock-share-price/alkem-laboratories-ltd/ALKEM/539523/

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did!

Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries

32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged.

We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA – UK, SAHPRA-South Africa, TGA – Australia, ANVISA – Brazil, WHO – Geneva, TPD – Health Canada, PPB – Kenya, NDA – Uganda, MOH – Sudan, INVIMA – Colombia, TFDA – Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries.

Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it’s Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.

Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

Alkem Laboratories Ltd. stand with []

Company Website: http://www.alkemlabs.com/
Company Website2: http://www.alkemlabs.com/
LinkedIn page URL: https://in.linkedin.com/company/alkem-laboratories-ltd
Wiki Profile URL: https://en.wikipedia.org/wiki/Alkem_Laboratories

Popular Search Keywords: alkem laboratories limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Generic industry

#alkem #laboratories #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #generic #industry

The post Alkem Laboratories Limited Company Profile | KooCapital.Com appeared first on KooCapital.Com.

Lupin Limited is an innovation led transnational pharmaceutical company, which engages in the manufacture of pharmaceutical products. It offers branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The firm caters to the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drug therapy, anti-tuberculosis, and cephalosporins industry segments. It operates through the following geographical segments: India, USA, Japan, and Others. The company was founded by Desh Bandhu Gupta in 1968 and is headquartered in Mumbai, India.

lupin limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Generic. lupin limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE326A01037
Equity Stock (National Stock Exchange) Symbol: LUPIN
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=LUPIN
BSE Link IS: https://www.bseindia.com/stock-share-price/lupin-ltd/LUPIN/500257/

Lupin is engaged in the business of Manufacture of Pharmaceuticals.

Manufacturing facilities and regulatory compliance
Lupin has 15 manufacturing facilities with 3 of these located outside India (1 each in USA, Mexico and Brazil). Alongside, Lupin has 6 API facilities, 7 research facilities and >20 global offices.

Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a significant player in the US, India and Japan and additionally in other counties within APAC, EMEA and LATAM. It holds a global leadership position in Anti-TB and Cephalosporin segments. Today Lupin is focused on building a meaningful pipeline in women’s health in USA, Neurology in Europe and Japan, Cardiac, Diabetes and Respiratory in India and Ophthalmic and Dermatology in LATAM. With 18 world class manufacturing facilities benchmarked to international standards, are spread across India, Japan, USA, Mexico and Brazil. Our 20,000 strong team of experts embrace the values of Lupin to create a winning culture as well as engage in leading research programs from new drug discovery to generic research that is helping us meet the unmet medical needs of our customers around the world.

Lupin stand with slogan [There is only one reason why we exist — to treat diseases, to heal and enrich human life.]

Company Website: http://www.lupin.com/
Company Website2: https://www.lupin.com/
LinkedIn page URL: https://in.linkedin.com/company/lupin
Wiki Profile URL: https://en.wikipedia.org/wiki/Lupin_Limited

Popular Search Keywords: lupin limited, company management, company history, company profile, company information, business directory, Stock Market News, annual report, quarterly results, profit and loss, Koo Capital, KooCapital.Com, KooCapital News, Health Technology Sector Company, Pharmaceuticals: Generic industry

#lupin #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #generic #industry

The post Lupin Limited Company Profile – KooCapital.Com | Stock Market News appeared first on KooCapital.Com.